| Financial Year |
March 31 2023 |
| Monetary Funds |
220,358,957.08 |
| Held-for-trading Financial Assets |
285,328,319.50 |
| Notes Receivable |
33,433,664.29 |
| Accounts Receivable |
394,791,408.39 |
| Advances to Suppliers |
1,617,407.03 |
| Other Receivables |
196,950.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
69,378,097.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
230,354.35 |
| Total Current Assets |
1,005,335,158.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
15,384,289.79 |
| Fixed Assetes |
122,467,532.78 |
| Under-construction Projects |
593,327.86 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,377,488.97 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
56,298.67 |
| Deferred Income Tax Assets |
12,414,256.38 |
| Other Non-Current Assets |
410,011,921.22 |
| Sub-Total of Non-Current Assets |
562,347,496.95 |
| Total Assets |
1,567,682,655.10 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
23,817,563.10 |
| Accounts Payable |
153,564,943.71 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,391,518.72 |
| Taxes Payable |
8,630,224.36 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
161,077.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
29,562.55 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
189,569,432.92 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
23,321.52 |
| Deferred Income Tax Liabilities |
49,247.93 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
72,569.45 |
| Total Liabilities |
189,642,002.37 |
| Paid-In Capital(Or Share Stock) |
60,000,000.00 |
| Capital Surplus |
1,017,695,638.77 |
| Surplus Reserve |
27,907,703.66 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
255,254,380.50 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,378,040,652.73 |
| Owner's Equity（Stockholder's Equity） |
1,378,040,652.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,567,682,655.10 |
